Professor Janaki Amin

Christie V; Rice M; Dracakis J; Green D; Amin J; Littlejohn K; Pyke C; McCowen D; Gwynne K, 2022, 'Improving breast cancer outcomes for Aboriginal women: A mixed-methods study protocol', BMJ Open, vol. 12, pp. e048003, http://dx.doi.org/10.1136/bmjopen-2020-048003

Lystad RP; Pulido DF; Peters L; Johnstone M; Ellis LA; Braithwaite J; Wuthrich V; Amin J; Cameron CM; Mitchell RJ, 2022, 'Feasibility of Monitoring Health and Well-being in Emerging Adults: Pilot Longitudinal Cohort Study', JMIR Formative Research, vol. 6, pp. e30027, http://dx.doi.org/10.2196/30027

Valerio H; Alavi M; Law M; McManus H; Tillakeratne S; Bajis S; Martinello M; Matthews GV; Amin J; Janjua NZ; Krajden M; George J; Degenhardt L; Grebely J; Dore GJ, 2021, 'Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study', Clinical Infectious Diseases, vol. 73, pp. 2037 - 2044, http://dx.doi.org/10.1093/cid/ciab526

Mwasakifwa GE; Amin J; Kelleher A; Boyd MA, 2021, 'Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure', AIDS (London, England), vol. 35, pp. 2289 - 2298, http://dx.doi.org/10.1097/QAD.0000000000003014

Jin F; Amin J; Guy R; Vaccher S; Selvey C; Zablotska I; Holden J; Price K; Yeung B; Ogilvie E; Quichua GC; Clackett S; McNulty A; Smith D; Templeton DJ; Bavinton B; Grulich AE, 2021, 'Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia', AIDS (London, England), vol. 35, pp. 1987 - 1996, http://dx.doi.org/10.1097/QAD.0000000000002970

Wong IKJ; Grulich AE; Poynten IM; Polizzotto MN; van Leeuwen MT; Amin J; McGregor S; Law M; Templeton DJ; Vajdic CM; Jin F, 2021, 'Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012', HIV Medicine, http://dx.doi.org/10.1111/hiv.13179

Chutiyami M; Wyver S; Amin J, 2021, 'Parent engagement with the New South Wales child health home-based record: A cross-sectional survey and a retrospective chart review', Child: Care, Health and Development, vol. 47, pp. 635 - 644, http://dx.doi.org/10.1111/cch.12871

Bavinton BR; Vaccher S; Jin F; Prestage GP; Holt M; Zablotska-Manos IB; Guy R; Amin J; Templeton DJ; Yeung B; Hammoud MA; Lewis D; Baker D; Dharan N; McNulty AM; Grulich AE, 2021, 'High Levels of Prevention-Effective Adherence to HIV PrEP: An Analysis of Substudy Data From the EPIC-NSW Trial', Journal of acquired immune deficiency syndromes (1999), vol. 87, pp. 1040 - 1047, http://dx.doi.org/10.1097/QAI.0000000000002691

Grulich AE; Jin F; Bavinton BR; Yeung B; Hammoud MA; Amin J; Cabrera G; Clackett S; Ogilvie E; Vaccher S; Vickers T; McNulty A; Smith DJ; Dharan NJ; Selvey C; Power C; Price K; Zablotska I; Baker DA; Bloch M; Brown K; Carmody CJ; Carr A; Chanisheff D; Doong N; Finlayson R; Lewis DA; Lusk J; Martin S; Ooi C; Read P; Ryder N; Smith D; Tuck Meng Soo C; Templeton DJ; Vlahakis E; Guy R, 2021, 'Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study', The Lancet HIV, vol. 8, pp. e486 - e494, http://dx.doi.org/10.1016/S2352-3018(21)00074-6

Valerio H; Alavi M; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Holden J; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Dore GJ; Grebely J, 2021, 'Progress towards Elimination of Hepatitis C Infection among People Who Inject Drugs in Australia: The ETHOS Engage Study', Clinical Infectious Diseases, vol. 73, pp. E69 - E78, http://dx.doi.org/10.1093/cid/ciaa571

Chutiyami M; Wyver S; Amin J, 2021, 'Predictors of Parent Use of a Child Health Home-Based Record and Associations with Long-Term Child Health/Developmental Outcomes: Findings from the Longitudinal Study of Australian Children from 2004 to 2016', Journal of Pediatric Nursing, vol. 59, pp. e70 - e76, http://dx.doi.org/10.1016/j.pedn.2021.02.002

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ; Loveday S; Tamaddoni M; Obeid S; Estivill Mercade G; Martinez M; Donnelly R; Bowman J; Trevethan L; Lagios K; Murrell T; Bath N; Tawil V; Stevens A; Topp L; Churchill A; Pinnock K; Drew S; Harrod M; Smith A; Williams R; Cooper B; Somes K; Burns C; Kaur A; Lobo C; Conroy K; McCredie L; Café C; Anlezark J; Rawlinson W; Yeang M; Wynn M; Willenborg C, 2021, 'Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study', The Lancet Gastroenterology and Hepatology, vol. 6, pp. 533 - 546, http://dx.doi.org/10.1016/S2468-1253(21)00077-7

Shajahan S; Amin J; Phillips JK; Hildreth CM, 2021, 'Relationship between sex and cardiovascular mortality in chronic kidney disease: A systematic review and meta-analysis', PLoS ONE, vol. 16, http://dx.doi.org/10.1371/journal.pone.0254554

Lau A; Kong FYS; Fairley CK; Templeton DJ; Amin J; Phillips S; Law M; Chen MY; Bradshaw CS; Donovan B; McNulty A; Boyd MA; Timms P; Chow EPF; Regan DG; Khaw C; Lewis DA; Kaldor J; Ratnayake M; Carvalho N; Hocking JS, 2021, 'Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis', New England Journal of Medicine, vol. 384, pp. 2418 - 2427, http://dx.doi.org/10.1056/NEJMoa2031631

Christie V; Green D; Amin J; Pyke C; Littlejohn K; Skinner J; McCowen D; Gwynne K, 2021, 'What is the evidence globally for culturally safe strategies to improve breast cancer outcomes for indigenous women in high income countries? A systematic review', International Journal of Environmental Research and Public Health, vol. 18, http://dx.doi.org/10.3390/ijerph18116073

Cunningham EB; Hajarizadeh B; Amin J; Hellard M; Bruneau J; Feld JJ; Cooper C; Powis J; Litwin AH; Marks P; Dalgard O; Conway B; Moriggia A; Stedman C; Read P; Bruggmann P; Lacombe K; Dunlop A; Applegate TL; Matthews GV; Fraser C; Dore GJ; Grebely J, 2021, 'Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection among People Who Inject Drugs', Clinical Infectious Diseases, vol. 72, pp. 1392 - 1400, http://dx.doi.org/10.1093/cid/ciaa253

Valerio H; Alavi M; Law M; Tillakeratne S; Amin J; Janjua NZ; Krajden M; George J; Matthews GV; Hajarizadeh B; Degenhardt L; Grebely J; Dore GJ, 2021, 'High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia', Journal of Hepatology, vol. 74, pp. 293 - 302, http://dx.doi.org/10.1016/j.jhep.2020.08.038

Chan C; Fraser D; Vaccher S; Yeung B; Jin F; Amin J; Dharan NJ; Carr A; Ooi C; Vaughan M; Holden J; Power C; Grulich AE; Bavinton BR, 2021, 'Overcoming barriers to HIV pre-exposure prophylaxis (PrEP) coverage in Australia among Medicare-ineligible people at risk of HIV: Results from the MI-EPIC clinical trial', Sexual Health, vol. 18, pp. 453 - 459, http://dx.doi.org/10.1071/SH21096

Mcmanus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; Mcnulty A; Smith D; Guy R, 2020, 'Comparison of Trends in Rates of Sexually Transmitted Infections before vs after Initiation of HIV Preexposure Prophylaxis among Men Who Have Sex with Men', JAMA Network Open, vol. 3, pp. e2030806, http://dx.doi.org/10.1001/jamanetworkopen.2020.30806

Cunningham EB; Hajarizadeh B; Amin J; Litwin AH; Gane E; Cooper C; Lacombe K; Hellard M; Read P; Powis J; Dalgard O; Bruneau J; Matthews GV; Feld JJ; Dillon JF; Shaw D; Bruggmann P; Conway B; Fraser C; Marks P; Dore GJ; Grebely J, 2020, 'Adherence to once-daily and twice-daily direct-acting antiviral therapy for Hepatitis C infection among people with recent injection drug use or current opioid agonist therapy', Clinical Infectious Diseases, vol. 71, pp. E115 - E124, http://dx.doi.org/10.1093/cid/ciz1089

Mwasakifwa GE; Amin J; White CP; Center JR; Kelleher A; Boyd MA, 2020, 'Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study', HIV Medicine, vol. 21, pp. 492 - 504, http://dx.doi.org/10.1111/hiv.12882

Chutiyami M; Wyver S; Amin J, 2020, 'Is parent engagement with a child health home-based record associated with parents perceived attitude towards health professionals and satisfaction with the record? A cross-sectional survey of parents in New South Wales, Australia', International Journal of Environmental Research and Public Health, vol. 17, pp. 1 - 11, http://dx.doi.org/10.3390/ijerph17155520

Dore G; Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Mcmanus H; Butler T; Vickerman P; Martin N; Mchutchison J; Brainard D; Treloar C; Lloyd A, 2020, 'Declining HCV incidence following rapid HCV treatment scale-up in a prison network in Australia: Evidence of treatment as prevention from the SToP-C study', JOURNAL OF HEPATOLOGY, vol. 73, pp. S127 - S127, http://dx.doi.org/10.1016/s0168-8278(20)30769-8

Valerio H; Alavi M; Matthews G; Law M; McManus H; Amin J; Janjua N; Krajden M; Tillakeratne S; Gleeson V; George J; Degenhardt L; Grebely J; Dore G, 2020, 'Opportunities to enhance linkage to hepatitis C care among people hospitalised for injection drug use-related complications: a population-based study', JOURNAL OF HEPATOLOGY, vol. 73, pp. S807 - S808, http://dx.doi.org/10.1016/s0168-8278(20)32060-2

Artenie AA; Cunningham EB; Dore GJ; Conway B; Dalgard O; Powis J; Bruggmann P; Hellard M; Cooper C; Read P; Feld JJ; Hajarizadeh B; Amin J; Lacombe K; Stedman C; Litwin AH; Marks P; Matthews GV; Quiene S; Erratt A; Bruneau J; Grebely J, 2020, 'Patterns of drug and alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis c virus treatment with directacting antiviral therapies: An international study', Clinical Infectious Diseases, vol. 70, pp. 2369 - 2376, http://dx.doi.org/10.1093/cid/ciz633

Lau A; Kong FYS; Fairley CK; Templeton DJ; Amin J; Boyd MA; Bradshaw C; Chen MY; Donovan B; Khaw C; Lewis DA; McNulty A; Regan DG; Ratnayake M; Hocking JS, 2020, 'Factors Associated with Early Resumption of Condomless Anal Sex among Men Who Have Sex with Men after Rectal Chlamydia Treatment', Sexually Transmitted Diseases, vol. 47, pp. 389 - 394, http://dx.doi.org/10.1097/OLQ.0000000000001166

Lystad RP; Pulido DF; Peters L; Johnstone M; Ellis LA; Braithwaite J; Wuthrich V; Amin J; Cameron CM; Mitchell RJ, 2020, 'Monitoring health and well-being in emerging adults: Protocol for a pilot longitudinal cohort study', JMIR Research Protocols, vol. 9, http://dx.doi.org/10.2196/16108

Chutiyami M; Wyver S; Amin J, 2020, 'Is parent engagement with a child health home-based record influenced by early child development and first-born status? hypotheses from a high-income countries’ perspective', Medical Hypotheses, vol. 137, http://dx.doi.org/10.1016/j.mehy.2020.109605

Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ, 2019, 'Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia', Journal of Hepatology, vol. 71, pp. 281 - 288, http://dx.doi.org/10.1016/j.jhep.2019.04.014

Jin F; Vajdic CM; Law M; Amin J; Van Leeuwen M; McGregor S; Poynten IM; Templeton DJ; Grulich AE, 2019, 'Incidence and time trends of anal cancer among people living with HIV in Australia', AIDS, vol. 33, pp. 1361 - 1368, http://dx.doi.org/10.1097/QAD.0000000000002218

Chutiyami M; Wyver S; Amin J, 2019, 'Are parent-held child health records a valuable health intervention? A systematic review and meta-analysis', International Journal of Environmental Research and Public Health, vol. 16, http://dx.doi.org/10.3390/ijerph16020220

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'SAT-232-Reinfection following successful HCV DAA therapy among people with recent injecting drug use', Journal of Hepatology, vol. 70, pp. e732 - e733, http://dx.doi.org/10.1016/s0618-8278(19)31465-3

Cunningham EB; Amin J; Feld JJ; Bruneau J; Dalgard O; Powis J; Hellard M; Cooper C; Read P; Conway B; Dunlop AJ; Norton B; Litwin AH; Hajarizadeh B; Thurnheer MC; Dillon JF; Weltman M; Shaw D; Bruggmann P; Gane E; Fraser C; Marks P; Applegate TL; Quiene S; Siriragavan S; Matthews GV; Dore GJ; Grebely J, 2018, 'Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study', International Journal of Drug Policy, vol. 62, pp. 14 - 23, http://dx.doi.org/10.1016/j.drugpo.2018.08.013

Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HMA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Smith D; Ooi C; Martin S; Soo TM; Templeton D; Townson D; Forssman B; Doong N; Han Thai G; Anderson B; MacLeod H; Parkhill N, 2018, 'Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study', The Lancet HIV, vol. 5, pp. e629 - e637, http://dx.doi.org/10.1016/S2352-3018(18)30215-7

Vanderven HA; Wragg K; Ana-Sosa-Batiz F; Kristensen AB; Jegaskanda S; Wheatley AK; Wentworth D; Wines BD; Hogarth PM; Rockman S; Kent SJ; INSIGHT FLU005 Pilot Study Writing Group , 2018, 'Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.', J Infect Dis, vol. 218, pp. 1383 - 1393, http://dx.doi.org/10.1093/infdis/jiy328

Lamoury FMJ; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty G; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL, 2018, 'Evaluation of a Hepatitis C Virus Core Antigen Assay in Plasma and Dried Blood Spot Samples', Journal of Molecular Diagnostics, vol. 20, pp. 621 - 627, http://dx.doi.org/10.1016/j.jmoldx.2018.05.010

Lamoury FMJ; Bajis S; Hajarizadeh B; Marshall AD; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing DH; Kleman M; Cunningham P; Dore GJ; Applegate TL; Grebely J, 2018, 'Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay', Journal of Infectious Diseases, vol. 217, pp. 1889 - 1896, http://dx.doi.org/10.1093/infdis/jiy114

Alavi M; Grebely J; Hajarizadeh B; Amin J; Larney S; Law MG; George J; Degenhardt L; Dore GJ, 2018, 'Mortality trends among people with hepatitis B and C: A population-based linkage study, 1993-2012', BMC Infectious Diseases, vol. 18, http://dx.doi.org/10.1186/s12879-018-3110-0

Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ, 2018, 'Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study', Journal of Viral Hepatitis, vol. 25, pp. 473 - 481, http://dx.doi.org/10.1111/jvh.12837

Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J, 2018, 'Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study', International Journal of Drug Policy, vol. 54, pp. 18 - 25, http://dx.doi.org/10.1016/j.drugpo.2017.12.013

Waziry R; Amin J; Law M; Dore GJ, 2018, 'Reply to: “Direct antiviral agents and risk of HCC: Waiting for Godot”', Journal of Hepatology, vol. 68, pp. 616 - 617, http://dx.doi.org/10.1016/j.jhep.2017.10.002

Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ, 2018, 'The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study', Journal of Hepatology, vol. 68, pp. 393 - 401, http://dx.doi.org/10.1016/j.jhep.2017.10.019

Grebely J; Dalgard O; Conway B; Cunningham EB; Bruggmann P; Hajarizadeh B; Amin J; Bruneau J; Hellard M; Litwin AH; Marks P; Quiene S; Siriragavan S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Dillon JF; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial', The Lancet Gastroenterology and Hepatology, vol. 3, pp. 153 - 161, http://dx.doi.org/10.1016/S2468-1253(17)30404-1

Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE, 2018, 'Erratum: Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial (BMC public health (2018) 18 1 (210))', BMC public health, vol. 18, pp. 297, http://dx.doi.org/10.1186/s12889-018-5173-7

Zablotska IB; Selvey C; Guy R; Price K; Holden J; Schmidt HM; McNulty A; Smith D; Jin F; Amin J; Cooper DA; Grulich AE; Parkhill N; Chant K; Cooper C; Crooks L; Allen D; Baker D; Bloch M; Bopage R; Brown K; Carr A; Carmody C; Collins K; Finlayson R; Foster R; Jackson E; Lewis D; Lusk J; O'Connor C; Ryder N; Vlahakis E; Read P; Yeung B; Levitt G; Ogilvie E; Vaccher S; Hammoud M; Watchirs-Smith L; Wabe N, 2018, 'Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): Design of an open label, single arm implementation trial', BMC Public Health, vol. 18, http://dx.doi.org/10.1186/s12889-017-5018-9

Mwasakifwa GE; Moore C; Carey D; Amin J; Penteado P; Losso M; Lim PL; Mohapi L; Molina JM; Gazzard B; Cooper DA; Boyd M, 2018, 'Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy', AIDS, vol. 32, pp. 357 - 361, http://dx.doi.org/10.1097/QAD.0000000000001688

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, vol. 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532

Waziry R; Hajarizadeh B; Grebely J; Amin J; Law M; Danta M; George J; Dore GJ, 2017, 'Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression', Journal of Hepatology, vol. 67, pp. 1204 - 1212, http://dx.doi.org/10.1016/j.jhep.2017.07.025

Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, vol. 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701

Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ, 2017, 'Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', International Journal of Drug Policy, vol. 47, pp. 177 - 186, http://dx.doi.org/10.1016/j.drugpo.2017.05.020

Madhavi V; Wines BD; Amin J; Emery S; Lopez E; Kelleher A; Center RJ; Mark Hogarth P; Chung AW; Kent SJ; Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, vol. 91, http://dx.doi.org/10.1128/JVI.00700-17

Midgard H; Hajarizadeh B; Cunningham EB; Conway B; Backmund M; Bruggmann P; Bruneau J; Bourgeois S; Dunlop A; Foster GR; Hellard M; Robaeys G; Thurnheer MC; Weltman M; Amin J; Marks PS; Quiene S; Dore GJ; Dalgard O; Grebely J, 2017, 'Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study', International Journal of Drug Policy, vol. 47, pp. 230 - 238, http://dx.doi.org/10.1016/j.drugpo.2017.05.040

Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, vol. 91, http://dx.doi.org/10.1128/JVI.00603-17

Madhavi V; Kulkarni A; Shete A; Lee WS; McLean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 345 - 353, http://dx.doi.org/10.1097/QAI.0000000000001380

Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL, 2017, 'Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study', The Lancet Gastroenterology and Hepatology, vol. 2, pp. 514 - 520, http://dx.doi.org/10.1016/S2468-1253(17)30075-4

Cunningham EB; Hajarizadeh B; Dalgard O; Amin J; Hellard M; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Bruneau J; Midgard H; Bourgeois S; Thurnheer MC; Dore GJ; Grebely J; Shaw I; Siriragavan S; Horschik T; Sharma S; Eevers A; Andreassen J; Melkeraaen I; Widder N; Lesneuck K; Kotsoros B; Hazelwood S; Holland R; Axten D; Von Bibra S; Powis J; Mason K; Ryder S; Jack K; Scheidegger C; Huber C; Ferguson C; Staehelin C; Lacalamita M; Fragomeli V; Sevehon A, 2017, 'Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study', BMC Infectious Diseases, vol. 17, http://dx.doi.org/10.1186/s12879-017-2517-3

Teeraananchai S; Kerr SJ; Amin J; Ruxrungtham K; Law MG, 2017, 'Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis', HIV Medicine, vol. 18, pp. 256 - 266, http://dx.doi.org/10.1111/hiv.12421

Lau A; Kong F; Fairley CK; Donovan B; Chen M; Bradshaw C; Boyd M; Amin J; Timms P; Tabrizi S; Regan DG; Lewis DA; McNulty A; Hocking JS, 2017, 'Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men - a double-blind randomised controlled trial protocol', BMC Infectious Diseases, vol. 17, http://dx.doi.org/10.1186/s12879-016-2125-7

Boyd MA; Amin J; Mallon PWG; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA, 2017, 'Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study', The Lancet HIV, vol. 4, pp. e13 - e20, http://dx.doi.org/10.1016/S2352-3018(16)30189-8

Hajarizadeh B; Grebely J; McManus H; Estes C; Razavi H; Gray RT; Alavi M; Amin J; McGregor S; Sievert W; Thompson A; Dore GJ, 2017, 'Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 32, pp. 229 - 236, http://dx.doi.org/10.1111/jgh.13453

Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ, 2017, 'Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000-2014)', Hepatology Communications, vol. 1, pp. 736 - 747, http://dx.doi.org/10.1002/hep4.1073

Amara AB; Else LJ; Carey D; Khoo S; Back DJ; Amin J; Emery S; Puls RL, 2017, 'Comparison of dried blood spots versus conventional plasma collection for the characterization of efavirenz pharmacokinetics in a large-scale global clinical trial-the ENCORE1 study', Therapeutic Drug Monitoring, vol. 39, pp. 654 - 658, http://dx.doi.org/10.1097/FTD.0000000000000448

Lee WS; Kristensen AB; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport M; Emery S; Amin J; Cooper DA; Kan V; Fox J; Grüll H; Parsons MS; Kent SJ; Rasmussen TA, 2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, vol. 3, pp. 10 - 10, http://dx.doi.org/10.1016/s2055-6640(20)30718-4

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study', Journal of Virus Eradication, vol. 3, pp. 2 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30889-x

Alavi M; Amin J; Grebely J; Law MG; Janjua NZ; Krajden M; Hajarizadeh B; George J; Matthews GV; Larney S; Degenhardt L; Dore GJ, 2017, 'O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study', Journal of Virus Eradication, vol. 3, pp. 9 - 9, http://dx.doi.org/10.1016/s2055-6640(20)30906-7

Cunningham E; Amin J; Bretana NA; Luciani F; Degenhardt L; Larney S; Hajarizadeh B; Dore GJ; Lloyd A; Grebely J, 2017, 'P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study', Journal of Virus Eradication, vol. 3, pp. 15 - 16, http://dx.doi.org/10.1016/s2055-6640(20)30751-2

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J, 2016, 'Hospitalization for anxiety and mood disorders in HIV-infected and -uninfected gay and bisexual men', Journal of Acquired Immune Deficiency Syndromes, vol. 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Petoumenos K; Zablotska IB; Poynten IM; Mao L; Law MG; Amin J, 2016, 'Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men.', J Acquir Immune Defic Syndr, vol. 73, pp. 589 - 597, http://dx.doi.org/10.1097/QAI.0000000000001147

Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ, 2016, 'Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014)', Journal of Hepatology, vol. 65, pp. 1086 - 1093, http://dx.doi.org/10.1016/j.jhep.2016.08.010

Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ, 2016, 'Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study', Journal of Hepatology, vol. 65, pp. 879 - 887, http://dx.doi.org/10.1016/j.jhep.2016.06.025

Moore CL; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Prestage G; Law MG; Grulich AE; Amin J, 2016, 'Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men', AIDS and Behavior, vol. 20, pp. 2372 - 2386, http://dx.doi.org/10.1007/s10461-016-1303-3

Achhra AC; Mwasakifwa G; Amin J; Boyd MA, 2016, 'Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis', The Lancet HIV, vol. 3, pp. e351 - e360, http://dx.doi.org/10.1016/S2352-3018(16)30015-7

Dickinson L; Amin J; Else L; Boffito M; Egan D; Owen A; Khoo S; Back D; Orrell C; Clarke A; Losso M; Phanuphak P; Carey D; Cooper DA; Emery S; Puls R, 2016, 'Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naïve HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study', Clinical Pharmacokinetics, vol. 55, pp. 861 - 873, http://dx.doi.org/10.1007/s40262-015-0360-5

Moore CL; Gidding HF; Law MG; Amin J, 2016, 'Poor record linkage sensitivity biased outcomes in a linked cohort analysis', Journal of Clinical Epidemiology, vol. 75, pp. 70 - 77, http://dx.doi.org/10.1016/j.jclinepi.2016.01.023

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, vol. 63, pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207

Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2

Moore CL; Grulich AE; Prestage G; Gidding HF; Jin F; Mao L; Petoumenos K; Zablotska IB; Poynten IM; Law MG; Amin J, 2016, 'Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men', HIV Medicine, vol. 17, pp. 327 - 339, http://dx.doi.org/10.1111/hiv.12312

Hajarizadeh B; Lamoury FMJ; Feld JJ; Amin J; Keoshkerian E; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection', Virology Journal, vol. 13, http://dx.doi.org/10.1186/s12985-016-0482-x

Martinello M; Amin J; Matthews GV; Dore GJ, 2016, 'Prevalence and disease burden of HCV coinfection in HIV cohorts in the Asia pacific region: A systematic review and meta-analysis', AIDS Reviews, vol. 18, pp. 69 - 80

Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Erratum: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection (PLoS ONE (2015)10:2 (e0118228) Doi: 10.1371/journal.pone.0118228 ))', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0140623

Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, vol. 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003

Dickinson L; Amin J; Else L; Boffito M; Egan D; Owen A; Khoo S; Back D; Orrell C; Clarke A; Losso M; Phanuphak P; Carey D; Cooper DA; Emery S; Puls R, 2015, 'Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naive HIV-Infected Patients: Results of the ENCORE1 Study', Clinical Pharmacology and Therapeutics, vol. 98, pp. 406 - 416, http://dx.doi.org/10.1002/cpt.156

Vajdic CM; Marashi Pour S; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'Corrigendum to "The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study" [Drug Alcohol Depend. 152C (2015) 264-271] DOI: 10.1016/j.drugalcdep.2015.03.026', Drug and Alcohol Dependence, vol. 154, pp. 304, http://dx.doi.org/10.1016/j.drugalcdep.2015.06.024

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; InC , 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC³ study', Journal of Viral Hepatitis, vol. 22, pp. 708 - 717, http://dx.doi.org/10.1111/jvh.12384

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437

Vajdic CM; Pour SM; Olivier J; Swart A; O'Connell DL; Falster MO; Meagher NS; Mao L; Grulich AE; Randall DA; Amin J; Burns L; Degenhardt L, 2015, 'The impact of blood-borne viruses on cause-specific mortality among opioid dependent people: An Australian population-based cohort study', Drug and Alcohol Dependence, vol. 152, pp. 264 - 271, http://dx.doi.org/10.1016/j.drugalcdep.2015.03.026

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, vol. 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5

Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK; PINT study team , 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, vol. 29, pp. 911 - 919, http://dx.doi.org/10.1097/QAD.0000000000000625

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ, 2015, 'Patterns of hepatitis C Virus RNA levels during acute infection: The InC³ study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0122232

Swart A; Meagher NS; Van Leeuwen MT; Zhao K; Grulich A; Mao L; Randall DA; Degenhardt L; Burns L; O'Connell D; Amin J; Vajdic CM, 2015, 'Examining the quality of name code record linkage: What is the impact on death and cancer risk estimates? A validation study', Australian and New Zealand Journal of Public Health, vol. 39, pp. 141 - 147, http://dx.doi.org/10.1111/1753-6405.12287

Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avinghsanon A; Chetchotisakd P; Khoo S; Cooper DA; Emery S; Puls R, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, vol. 60, pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976

Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic CM, 2015, 'Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study', Drug and Alcohol Dependence, vol. 148, pp. 213 - 216, http://dx.doi.org/10.1016/j.drugalcdep.2014.12.027

Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0118228

Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', The Lancet HIV, vol. 2, pp. e42 - e51, http://dx.doi.org/10.1016/S2352-3018(14)00061-7

Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ, 2015, 'Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatment', Journal of Hepatology, vol. 62, pp. 269 - 277, http://dx.doi.org/10.1016/j.jhep.2014.09.001

Lee FJ; Amin J; Carr A, 2015, 'Limited reporting of major harms in studies of initial combination antiretroviral therapy: A systematic review', AIDS, vol. 29, pp. 921 - 929, http://dx.doi.org/10.1097/QAD.0000000000000633

Yuneti ON; Sawitri AAS; Wulandari LPL; Muliawan P; Widyanthini DN; Kathy PK; Amin J; Mathers B; Kaldor JM; Merati TP; Wirawan DN, 2015, 'P16.18 Influence of baseline characteristics on the increase cd4 >350 cells/mm3 among HIV/AIDS patients receiving antiretroviral therapy in indonesia', Sexually Transmitted Infections, vol. 91, pp. A218.1 - A218, http://dx.doi.org/10.1136/sextrans-2015-052270.565

Larney S; Grebely J; Falster M; Swart A; Amin J; Degenhardt L; Burns L; Vajdic C, 2015, 'Diagnosis of hepatitis c virus infection after entry to opioid substitution therapy', Drug and Alcohol Dependence, vol. 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.337

Hajarizadeh B; Grady B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J; Lauer G; Shoukry NH; Hahn J; Shiboski S; Alavi M; Bouchard R; Aneja J; Teutsch S; White B; Wells B; Zang G; Matthews G; Marks P; Yeung B; Prince LE; Roy E; Bates A; Enriquez J; Chow S; McCredie L; Aitken C; Doyle J; Spelman T; Evans J, 2014, 'Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: The InC³ Study', Journal of Clinical Virology, vol. 61, pp. 430 - 434, http://dx.doi.org/10.1016/j.jcv.2014.08.027

Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, vol. 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), vol. 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), vol. 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643

Moore CL; Amin J; Gidding HF; Law MG, 2014, 'A new method for assessing how sensitivity and specificity of linkage studies affects estimation', PLoS ONE, vol. 9, pp. e103690, http://dx.doi.org/10.1371/journal.pone.0103690

Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomised to raltegravir/lopinavir/ritonavir compared to standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, http://dx.doi.org/10.1097/QAI.0000000000000288

Muscatello DJ; Amin J; MacIntyre CR; Newall AT; Rawlinson WD; Sintchenko V; Gilmour R; Thackway S, 2014, 'Inaccurate ascertainment of morbidity and mortality due to influenza in administrative databases: A population-based record linkage study', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0098446

Lee FJ; Amin J; Carr A, 2014, 'Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: A systematic review and meta-analysis of 114 studies with up to 144 weeks' follow-up', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0097482

Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0094858

Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0093333

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; Mcgovern BH; Schinkel J; George J; Shoukry NH; Lauer GM; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2014, 'The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection', Hepatology, vol. 59, pp. 109 - 120, http://dx.doi.org/10.1002/hep.26639

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, vol. 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X

Alavi M; Law MG; Grebely J; Thein HH; Walter S; Amin J; Dore GJ, 2014, 'Lower life expectancy among people with an HCV notification: A population-based linkage study', Journal of Viral Hepatitis, vol. 21, http://dx.doi.org/10.1111/jvh.12245

Amin J; Law MG; Puls R; Kelleher A; Cooper DA; Emery S, 2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, vol. 28, pp. 2480 - 2483, http://dx.doi.org/10.1097/QAD.0000000000000461

Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, vol. 67, pp. 161 - 168, http://dx.doi.org/10.1097/QAI.0000000000000288

Phetsouphanh C; Xu Y; Amin J; Seddiki N; Procopio F; Sekaly RP; Zaunders JJ; Kelleher AD, 2013, 'Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+ T Cells Using Qualitative Multiplex Single-Cell RT-PCR', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0074946

Wildan T; Amin J; Bowe D; Gerber B; Saeed NR, 2013, 'Dental foundation year 2 training in oral and maxillofacial surgery units - the trainees' perspective', BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, vol. 51, pp. E155 - E164, http://dx.doi.org/10.1016/j.bjoms.2012.06.001

Matthews GV; Ali RJ; Avihingsanon A; Amin J; Hammond RA; Bowden S; Lewin SR; Sasadeusz JJ; Littlejohn M; Locarnini SL; Ruxrungtham K; Dore GJ, 2013, 'Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals', PLoS One, vol. 8, pp. e61297, http://dx.doi.org/10.1371/journal.pone.0061297

Leenders FJ; Amin J; Bloch M; Pett SL; Marriott D; Carr AD, 2013, 'Skeletal muscle toxicity associated with raltegravir-based combination antiretroviral therapy in HIV-infected adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 62, pp. 525 - 533, http://dx.doi.org/10.1097/QAI.0b013e3182832578

Rodger AJ; Lodwick RK; Schechter M; Deeks SG; Amin J; Gilson RJC; Paredes R; Bakowska E; Engsig FN; Phillips AN, 2013, 'Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population', AIDS, vol. 27, pp. 973 - 979, http://dx.doi.org/10.1097/QAD.0b013e32835cae9c

Deans GD; Raffa JD; Lai C; Fischer B; Krajden M; Amin J; Walter SR; Dore GJ; Grebely J; Tyndall MW, 2013, 'Mortality in a large community-based cohort of inner-city residents in Vancouver, Canada.', CMAJ Open, vol. 1, pp. E68 - E76, http://dx.doi.org/10.9778/cmajo.20130002

Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 57 - 57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, vol. 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213

Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, vol. 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x

Brown D; Hance KW; Rogers C; Sansbury ; Albert P; Murphy G; Laiyemo A; Wang Z; Cross A; Schatzkin A; Danta M; Srasu ; Amin J; Law MG; Breit SN; Lanza E; Brown , 2012, 'Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer?', Cancer Epidemiology Biomarkers and Prevention, vol. 21, pp. 337 - 346, http://dx.doi.org/10.1158/1055-9965.EPI-11-0786

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, vol. 7, pp. e38377, http://dx.doi.org/10.1371/journal.pone.0038377

Hsu DC; Zaunders J; Plit ML; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey MR; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD, 2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, vol. 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008

Achhra AC; Amin J; Sabin C; Chu H; Dunn D; Kuller LH; Kovacs JA; Cooper DA; Emery S; Law MG, 2012, 'Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals', AIDS, vol. 26, pp. 1707 - 1717, http://dx.doi.org/10.1097/QAD.0b013e328355d659

Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; Stratov SI; Navis M; Kent SJ, 2012, 'Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection', Immunology, vol. 138, pp. 116 - 123, http://dx.doi.org/10.1111/imm.12016

Thein H; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ, 2012, 'Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort', Hepatology Research, vol. 42, pp. 1175 - 1186, http://dx.doi.org/10.1111/j.1872-034X.2012.01037.x

Gidding HF; Law MG; Amin J; Ostapowicz G; Weltman MD; Macdonald GAM; Sasadeusz JJ; Haber PS; George J; Dore GJ, 2012, 'Hepatitis C treatment outcomes in Australian clinics', Medical Journal of Australia, vol. 196, pp. 633 - 637, http://dx.doi.org/10.5694/mja12.10014

Achhra AC; Amin J, 2012, 'Race and CD4 + T-cell count in HIV prognosis and treatment', Future Virology, vol. 7, pp. 193 - 203, http://dx.doi.org/10.2217/fvl.11.143

Kumarasinghe G; Herrera C; Stuart S; Victor A; Amin J; Hayward C; MacDonald P; Danta M, 2011, 'Noninvasive assessment of liver fibrosis in cardiac disease', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 26, pp. 54 - 54, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000295157300141&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr A, 2011, 'Lower fat mass and lower bone formation predict greater bone loss with tenofovir in HIV-infected adults', ANTIVIRAL THERAPY, vol. 16, pp. A6 - A7, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cordery DV; Humphries A; Amin J; Kelleher AD; Emery S; Cooper DA, 2011, 'The influence of HLA supertype on thymidine analogue induced body composition changes in STEAL', ANTIVIRAL THERAPY, vol. 16, pp. A20 - A21, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, vol. 6, pp. Article number e26885, http://dx.doi.org/10.1371/journal.pone.0026885

Achhra AC; Zhou J; Choi JY; Hoy J; Zhang F; Templeton DJ; Merati T; Woolley I; Petoumenos K; Amin J, 2011, 'The clinical significance of CD4 counts in asian and caucasian HIV-infected populations: Results from TAHOD and AHOD', Journal of the International Association of Physicians in AIDS Care, vol. 10, pp. 160 - 170, http://dx.doi.org/10.1177/1545109711402213

Kariminia A; Chokephaibulkit K; Pang J; Lumbiganond P; Hansudewechakul R; Amin J; Kumarasamy N; Puthanakit T; Kurniati N; Yusoff N; Saphonn V; Fong SM; Razali K; Nallusamy R; Sohn A; Sirisanthana V, 2011, 'Cohort profile: The TREAT Asia pediatric HIV observational database', International Journal of Epidemiology, vol. 40, pp. 15 - 24, http://dx.doi.org/10.1093/ije/dyp358

Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, vol. 204, pp. 1532 - 1540, http://dx.doi.org/10.1093/infdis/jir559

Jackson A; Hill A; Puls R; Else L; Amin J; Back D; Lin E; Khoo S; Emery S; Morley R; Gazzard B; Boffito M, 2011, 'Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers', Journal of Antimicrobial Chemotherapy, vol. 66, pp. 635 - 640, http://dx.doi.org/10.1093/jac/dkq468

Walter SR; Thein H; Gidding HF; Amin J; George J; Dore GJ, 2011, 'Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C', Journal of Gastroenterology and Hepatology (JGH), vol. 26, pp. 1757 - 1764, http://dx.doi.org/10.1111/j.1440-1746.2011.06785.x

Gidding HF; Amin J; Dore GJ; Law MG, 2011, 'Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C', Epidemiology and Infection, vol. 139, pp. 1151 - 1158, http://dx.doi.org/10.1017/S095026881000258X

Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ, 2011, 'Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: A population-based cohort study, 1992-2007', Journal of Viral Hepatitis, vol. 18, pp. e232 - e241, http://dx.doi.org/10.1111/j.1365-2893.2011.01440.x

Gidding HF; Law MG; Amin J; MacDonald GJ; Sasadeusz JJ; Jones TL; Strasser SI; George J; Dore GJ, 2011, 'Predictors of deferral of treatment for hepatitis C infection in Australian clinics', The Medical Journal of Australia, vol. 194, pp. 398 - 402

Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ, 2011, 'Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006', Journal of Hepatology, vol. 54, pp. 879 - 886, http://dx.doi.org/10.1016/j.jhep.2010.08.035

Gidding HF; Dore GJ; Amin J; Law MG, 2011, 'Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study', BMC Public Health, vol. 11, pp. 52, http://dx.doi.org/10.1186/1471-2458-11-52

Chung AW; Navis M; Isitman G; Wren L; Silvers J; Amin J; Kent SJ; Stratov I, 2011, 'Activation of NK cells by ADCC antibodies and HIV disease progression', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 58, pp. 127 - 131, http://dx.doi.org/10.1097/QAI.0b013e31822c62b9

Achhra A; Phanuphak P; Amin J, 2011, 'Long-term immunological outcomes in treated HIV-infected individuals in high-income and low-middle income countries', Current opinion in HIV & AIDS, vol. 6, pp. 258 - 265, http://dx.doi.org/10.1097/COH.0b013e3283476c72

Wildan T; Amin J; Saeed N, 2011, 'Relevance of Dental Foundation Year 2 training in maxillofacial units', British Journal of Oral and Maxillofacial Surgery, vol. 49, pp. S25 - S25, http://dx.doi.org/10.1016/j.bjoms.2011.04.065

Danta M; Kumarasinghe G; Stuart S; Victor A; Amin J; Hayward C; Macdonald P, 2010, 'Liver elastography in cardiac disease (LECD) study', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 25, pp. A24 - A25, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Amin J; Martin A; Bloch M; Carr A, 2010, 'Reply to Landman and Soonawala', Clinical Infectious Diseases, vol. 50, pp. 1200 - 1201, http://dx.doi.org/10.1086/651469

Zheng H; Ehrlich F; Amin J, 2010, 'Quantifying the effect size of walking interventions to reduce the risk of coronary heart disease: Meta-analysis', International Journal of Body Composition Research, vol. 8, pp. S51 - S59, http://www.ijbcr.com/IJBCR_8_Supplement.pdf

Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, vol. 65, pp. 1878 - 1888, http://dx.doi.org/10.1093/jac/dkq231

Amin J; De lazzari E; Emery S; Martin A; Martinez E; Carr AD; Gatell J; Cooper DA, 2010, 'Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in treatment experienced, virologically suppressed adults with HIV infection: combined analysis of two randomised, non-inferiority trials Bicombo and Steal.', Journal of AIDS & Clinical Research, vol. 1, pp. 1001 - 1013, http://dx.doi.org/10.4172/2155-6113.1000103

Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, vol. 24, pp. 2657 - 2663, http://dx.doi.org/10.1097/QAD.0b013e32833f147f

Yan C; Hanafi I; Kelleher AD; Carr AD; Amin J; Mcnally L; Cunningham PH, 2010, 'Lack of correlation between three commerical platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification', Journal of Clinical Virology, vol. 49, pp. 249 - 253, http://dx.doi.org/10.1016/j.jcv.2010.08.016

Zheng H; Ehrlich F; Amin J, 2010, 'Productivity loss resulting from coronary heart disease in Australia', Applied Health Economics and Health Policy, vol. 8, pp. 179 - 189, http://dx.doi.org/10.2165/11530520-000000000-00000

Zheng H; Ehrlich F; Amin J, 2010, 'Economic evaluation of the direct healthcare cost savings resulting from the use of walking interventions to prevent coronary heart disease in Australia', International Journal of Health Care Finance and Economics, vol. 10, pp. 187 - 201, http://dx.doi.org/10.1007/s10754-009-9074-2

Cordery D; Hesse K; Amin J; Cooper DA; Hesse , 2010, 'Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients', Antiviral Therapy, vol. 15, pp. 1035 - 1038, http://dx.doi.org/10.3851/IMP1647

Achhra A; Amin J; Law MG; Emery S; Gerstoft J; Gordin F; Vjecha M; Neaton JD; Cooper DA, 2010, 'Immunodeficiency and the risk of serious clinical endpoints in a well-studied cohort of treated HIV-infected patients.', AIDS, vol. 24, pp. 1877 - 1886, http://dx.doi.org/10.1097/QAD.0b013e32833b1b26

Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, vol. 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850

Gidding HF; Amin J; Dore GJ; Ward K; Law MG, 2010, 'Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia', Journal of Hepatology, vol. 53, pp. 43 - 49, http://dx.doi.org/10.1016/j.jhep.2010.01.036

Van Leeuwen MT; Webster AC; Mccredie MR; Stewart JH; McDonald S; Amin J; Kaldor JM; Chapman JR; Vajdic CM; Grulich AE, 2010, 'Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.', British Medical Journal (BMJ), vol. 340, pp. c570, http://dx.doi.org/10.1136/bmj.c570

Salmon A; Van Beek I; Amin J; Kaldor JM; Maher L, 2010, 'The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia', Addiction, vol. 105, pp. 676 - 683, http://dx.doi.org/10.1111/j.1360-0443.2009.02837.x

Jackson AGA; Hill A; Else LJ; Back DJ; Morley R; Puls R; Amin J; Lin E; Boffito M, 2010, 'Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers', Journal of the International AIDS Society, vol. 13, pp. P180 - P180, http://dx.doi.org/10.1186/1758-2652-13-s4-p180

Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, vol. 49, pp. 1591 - 1601, http://dx.doi.org/10.1086/644769

Zheng H; Orsini N; Amin J; Wolk A; Nguyen VT; Ehrlich F, 2009, 'Quantifying the dose-response of walking in reducing coronary heart disease risk: Meta-analysis', European Journal of Epidemiology, vol. 24, pp. 181 - 192, http://dx.doi.org/10.1007/s10654-009-9328-9

Razali K; Amin J; Dore GJ; Law MG, 2009, 'Modelling and calibration of the hepatitis C epidemic in Australia', Statistical Methods in Medical Research, vol. 18, pp. 253 - 270, http://dx.doi.org/10.1177/0962280208094689

Van Leeuwen MT; Grulich AE; Webster A; Mccredie M; Stewart JS; McDonald S; Amin J; Kaldor JM; Chapman JR; Vajdic CM, 2009, 'Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation', Blood, vol. 114, pp. 630 - 637, http://dx.doi.org/10.1182/blood-2009-02-202507

Stewart J; Vajdic CM; Van Leeuwen MT; Amin J; Webster A; McDonald S; Chapman JR; Grulich AE; Mccredie M, 2009, 'The pattern of excess cancer in dialysis and transplantation', Nephrology Dialysis Transplantation, vol. 24, pp. 3225 - 3231, http://dx.doi.org/10.1093/ndt/gfp331

Vajdic CM; Van Leeuwen MT; Webster A; Mccredie M; Stewart J; Chapman JR; Amin J; Grulich AE; McDonald S, 2009, 'Cutaneous melanoma is related to immune suppression in kidney transplant recipients', Cancer epidemiology biomarkers and prevention, vol. 18, pp. 2297 - 2303, http://dx.doi.org/10.1158/1055-9965.EPI-09-0278

Van Leeuwen MT; Grulich AE; McDonald S; Mccredie M; Amin J; Stewart J; Webster A; Chapman JR; Vajdic CM, 2009, 'Immunosuppression and other risk factors for lip cancer after kidney transplantation', Cancer epidemiology biomarkers and prevention, vol. 18, pp. 561 - 569, http://dx.doi.org/10.1158/1055-9965.EPI-08-0919

Salmon A; Van Beek I; Amin J; Grulich A; Maher L, 2009, 'High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre', Australian and New Zealand Journal of Public Health, vol. 33, pp. 280 - 283, http://dx.doi.org/10.1111/j.1753-6405.2009.00389.x

Alcantara S; Reece J; amarasena T; De Rose R; Manitta J; Amin J; Kent SJ, 2009, 'Thrombocytopenia is strongly associated with simian AIDS in pigtail macaques', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 51, pp. 374 - 379, http://dx.doi.org/10.1097/QAI.0b013e3181a9cbcf

Nguyen VT; Amin J; Law MG; Dore GJ, 2009, 'Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia', Journal of Gastroenterology and Hepatology, vol. 24, pp. 436 - 442, http://dx.doi.org/10.1111/j.1440-1746.2008.05577.x

Carr AD; Amin J, 2009, 'Efficacy and tolerability of initial antiretroviral therapy: A systematic review', AIDS, vol. 23, pp. 343 - 353, http://dx.doi.org/10.1097/QAD.0b013e32831db232

Nguyen VT; Razali K; Amin J; Law MG; Dore GJ, 2008, 'Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries', Journal of Gastroenterology and Hepatology, vol. 23, pp. 922 - 929, http://dx.doi.org/10.1111/j.1440-1746.2007.05065.x

Matthews G; Avihingsanon A; Lewin S; Amin J; Rerknimitr R; Petcharapirat P; Marks PB; Sasadeusz J; Cooper DA; Bowden S; Locarnini S; Ruxrungtham K; Dore GJ, 2008, 'A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand', Hepatology, vol. 48, pp. 1062 - 1069, http://dx.doi.org/10.1002/hep.22462

Amin J; Law MG, 2007, 'Causes of death in hepatitis B and C: a methodological issue', Lancet, vol. 370, pp. 1033, http://dx.doi.org/10.1016/S0140-6736(07)61473-1

Micallef JM; Macdonald V; Jauncey ME; Amin J; Rawlinson WD; Van Beek IA; Kaldor JM; White PA; Dore GJ, 2007, 'High Incidence of hepatitis C virus reinfection within a cohort of injecting drug users', Journal of Viral Hepatitis, vol. 14, pp. 413 - 418, http://dx.doi.org/10.1111/j.1365-2893.2006.00812.x

Amin J; Law MG; Micallef JM; Jauncey ME; Van Beek IA; Kaldor JM; Dore GJ, 2007, 'Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users', Epidemiology and Infection, vol. 135, pp. 144 - 150, http://dx.doi.org/10.1017/S0950268806006388

Amin J; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Law MG; Dore GJ, 2007, 'Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study', Australian and New Zealand Journal of Public Health, vol. 31, pp. 475 - 482, http://dx.doi.org/10.1111/j.1753-6405.2007.00121.x

Macdonald V; Dore GJ; Amin J; Van Beek IA, 2007, 'Predictors of completion of a hepatitis Bvaccination schedule in attendees at a primary health care centre.', Sexual Health, vol. 4, pp. 27 - 30, http://dx.doi.org/10.1071/SH06008

Amin J; Law MG; Dore G, 2006, 'Mortality in patients with hepatitis B or hepatitis C - Authors' reply', Lancet, vol. 368, pp. 1767, http://dx.doi.org/10.1016/S0140-6736(06)69729-8

Dwyer D; Workman C; Hales GP; Amin J; Cooper DA; Miller J; Emery S, 2006, 'Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study', Antiviral Therapy, vol. 11, pp. 409 - 419

Winston A; Amin J; Hales GP; Cooper DA; Emery S, 2006, 'Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals', AIDS Research and Human Retroviruses, vol. 22, pp. 338 - 341, http://dx.doi.org/10.1089/aid.2006.22.338

Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, vol. 7, pp. 105 - 111, http://dx.doi.org/10.1111/j.1468-1293.2006.00349.x

Brown DA; Stephan C; Ward RL; Law MG; Hunter M; Bauskin AR; Amin J; Jung K; Diamandis E; Hampton GM; Russell PJ; Giles GG; Breit SN, 2006, 'Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostate-specific antigen improves prostate cancer diagnosis', Clinical Cancer Research, vol. 12, pp. 89 - 96, http://dx.doi.org/10.1158/1078-0432.CCR-05-1331

Amin J; Law MG; Bartlett M; Kaldor JM; Dore GJ, 2006, 'Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study', Lancet, vol. 368, pp. 938 - 945, http://dx.doi.org/10.1016/S0140-6736(06)69374-4

Amin J; Dore GJ; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Law MG, 2006, 'Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study', Journal of Hepatology, vol. 45, pp. 197 - 203, http://dx.doi.org/10.1016/j.jhep.2006.02.014

Hamlyn E; McAllister J; Winston A; Sinclair B; Amin J; Carr AD; Cooper DA, 2006, 'Is screening for sexually transmitted infections in men who have sex with men who receive non-occupational HIV post-exposure prophylaxis worthwhile?', Sexually Transmitted Infections, vol. 82, pp. 21 - 23, http://dx.doi.org/10.1136/sti.2005.014662

Winston A; Hales GP; Amin J; van Schaick E; Cooper DA; Emery S, 2005, 'The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals', AIDS, vol. 19, pp. 1393 - 1399, http://dx.doi.org/10.1097/01.aids.0000181009.77632.36

Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, vol. 56, pp. 380 - 387, http://dx.doi.org/10.1093/jac/dki235

Winston A; McAllister J; Amin J; Cooper DA; Carr AD, 2005, 'The use of a triple nucleoside-nucleotide-regimen for occupational HIV post-exposure prophylaxis', HIV Medicine, vol. 6, pp. 191 - 197, http://dx.doi.org/10.1111/j.1468-1293.2005.00288.x

Grulich AE; Cunningham PH; Munier CM; Prestage G; Amin J; Ringland C; Whitby D; Kippax SC; Kaldor JM; Rawlinson WD, 2005, 'Sexual behaviour and human herpesvirus 8 infection in homosexual men in Australia.', Sexual Health, vol. 2, pp. 13 - 18, http://dx.doi.org/10.1071/SH04029

Hallinan R; Byrne A; Amin J; Dore GJ, 2005, 'Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy', Journal of Gastroenterology and Hepatology, vol. 20, pp. 1082 - 1086, http://dx.doi.org/10.1111/j.1440-1746.2005.03882.x

Amin J; Law MG; O Connell DL; Bartlett M; Tracey E; Kaldor JM; Dore GJ, 2005, 'Cancer incidence in people with hepatitis B or C infection: A population based cohort study', Journal of Hepatology, vol. 42, pp. 88 - 88, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229024000228&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Martin A; Smith DE; Carr AD; Ringland C; Amin J; Emery S; Hoy JF; Workman C; Doong N; Freund J; Cooper DA, 2004, 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study', AIDS, vol. 18, pp. 1029 - 1036, http://dx.doi.org/10.1097/00002030-200404300-00011

Amin J; Kaye M; Skidmore S; Pillay D; Cooper DA; Dore GJ, 2004, 'HIV and hepatitis C coinfection within the CAESAR study', HIV Medicine, vol. 5, pp. 174 - 179, http://dx.doi.org/10.1111/j.1468-1293.2004.00207.x

Moyle GJ; Sawyer W; Law MG; Amin J; Hill A, 2004, 'Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: A meta-analysis of six prospective, randomized, comparative studies', Clinical Therapeutics, vol. 26, pp. 92 - 97, http://dx.doi.org/10.1016/S0149-2918(04)90009-4

Jauncey ME; Micallef JM; Gilmour S; Amin J; White PA; Rawlinson WD; Kaldor JM; Van Beek IA; Dore GJ, 2004, 'Clearance of hepatitis C virus after newly acquired infection ininjection drug users', Journal of Infectious Diseases, vol. 190, pp. 1270 - 1274, http://dx.doi.org/10.1086/423943

Hallinan R; Amin J; Dore GJ, 2004, 'Hepatitis C virus incidence among injecting drug users on opioid replacement therapy', Australian and New Zealand Journal of Public Health, vol. 28, pp. 576 - 578, http://dx.doi.org/10.1111/j.1467-842X.2004.tb00050.x

Amin J; Moore A; Carr AD; French MA; Law MG; Emery S; Cooper DA, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, vol. 4, pp. 252 - 261, http://dx.doi.org/10.1310/K2U9-QC2V-1Y3V-5DYF

MICALLEF J; JAUNCEY M; AMIN J; RAWLINSON W; GILMOUR S; VANBEEK I; KALDOR J; WHITE P; DORE G, 2003, '229 Hepatitis C virus reinfection within a cohort of injecting drug users', Hepatology, vol. 38, pp. 266 - 266, http://dx.doi.org/10.1016/s0270-9139(03)80272-0

Mikhailof N; Carr A; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy [1] (multiple letters)', Journal of the American Medical Association, vol. 288, pp. 1716, http://dx.doi.org/10.1001/jama.288.14.1716

Carr AD; Workman C; Smith DE; Hoy JF; Doong N; Amin J; Law MG; Cooper DA, 2002, 'For the MITOX investigators: Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial', Journal of the American Medical Association, vol. 288, pp. 207 - 215

Miller J; Brown DA; Amin J; Kent-Hughes J; Law MG; Cooper DA; Carr AD, 2002, 'A randomised, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemia', AIDS, vol. 16, pp. 2195 - 2200, http://dx.doi.org/10.1097/00002030-200211080-00012

Carr AD; Workman C; Smith DE; Hoy JF; Hudson J; Doong N; Martin A; Amin J; Freund J; Law MG; Cooper DA, 2002, 'Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy', JAMA - Journal of the American Medical Association, vol. 288, pp. 207 - 215, http://dx.doi.org/10.1001/jama.288.2.207

Carr AD; Amin J; Cooper DA, 2002, 'Insulin resistance and HIV-related lipoatrophy', Journal of the American Medical Association, vol. 288, pp. 1716, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178484700016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

French MA; Amin J; Roth N; Law MG; Emery S; Drummond F, 2002, 'Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: The OzCombo 2 Study', HIV Clinical Trials, vol. 3, pp. 177 - 185, http://dx.doi.org/10.1310/9N21-1HG1-7N1Q-JKW1

Amin J; Gilbert GL; escott R; heath T; Burgess MA, 2001, 'Hepatitis A epidemiology in Australia: national seroprevalence and notifications', Medical Journal of Australia, vol. 174, pp. 338 - 341

McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M, 2000, 'Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.', Communicable diseases intelligence, vol. 24, pp. 276 - 277

McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M, 2000, 'Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.', Communicable diseases intelligence, vol. Suppl

Gidding HF; Amin J; McIntyre PB, 2000, 'Notifications of vaccine preventable diseases in Australia. Quarterly report (January-March 2000).', Communicable diseases intelligence, vol. 24, pp. 239 - 241

McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M, 2000, 'Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.', Commun Dis Intell, vol. Suppl, pp. v - 83, https://www.ncbi.nlm.nih.gov/pubmed/12049363

Amin J; McIntyre P; Gidding H; Turnbull F; Burgess M, 2000, 'Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998', Communicable Diseases Intelligence Quarterly Report

Thomson J; Lin M; Halliday L; Preston G; McIntyre P; Gidding H; Amin J; Roberts L; Higgins K; Brooke F; Milton A; O'Brien E; Witteveen D; Crerar S, 1999, 'Australia's notifiable diseases status, 1998. Annual report of the National Notifiable Diseases Surveillance System.', Communicable diseases intelligence, vol. 23, pp. 277 - 305

Amin J; Wong M, 1999, 'Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update', Communicable Diseases Intelligence Quarterly Report

Heath T; Amin J; Morrell SL, 1999, 'Hepatitis A in Australia in the 1990s: future directions in surveillance and control', Communicable Diseases Intelligence, vol. 23, pp. 113 - 120

Amin J; Hueston L; Dwyer DE; Capon A, 1998, 'Ross River virus infection in the north-west outskirts of the Sydney basin', Communicable Diseases Intelligence Quarterly Report, vol. 22, pp. 101 - 102

Amin J; McIntyre PB; Heath TC, 1998, 'Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern?', Communicable diseases intelligence, vol. 22, pp. 58 - 59

Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; Butler T; Vickerman P; Martin NK; Mchutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore GJ, 2017, 'Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the SToP-C study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S274 - S274, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30862-0

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1

Hajarizadeh B; Grebely J; Byrne M; Marks P; Butler T; Amin J; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Lloyd AR; Dore G, 2016, 'Hepatitis C virus exposure, infection and associated risk behaviours in two maximum-security prisons in New South Wales, Australia', in HEPATOLOGY, WILEY, Boston, MA, pp. 385A - 386A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 11 November 2016 - 15 November 2016, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493802052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Waziry RK; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews G; Law M; Dore G, 2015, 'Trends in end-stage liver disease among people notified with HBV or HCV in New South Wales, Australia: 2000-2014', in HEPATOLOGY, WILEY-BLACKWELL, San Francisco, CA, pp. 1121A - 1121A, presented at 66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), San Francisco, CA, 13 November 2015 - 17 November 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368375404114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady B; Page K; Kim AY; Mcgovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Schinkel J; Applegate T; Maher L; Hellard M; Lloyd AR; Prins M; Geskus RB; Dore GJ; Grebely J, 2015, 'Factors associated with hepatitis C virus RNA levels in early chronic infection: The InC3 study', in Journal of Viral Hepatitis, Blackwell Publishing Ltd, http://dx.doi.org/10.1111/jvh.12384

Alavi M; Law M; Grebely J; Thein H-H; Amin J; Dore GJ, 2014, 'Time to hepatocellular carcinoma after notification of hepatitis B or C infection: a population-based cohort study, 1992-2007', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 921A - 922A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 November 2014 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Grady BP; Page K; Kim AY; McGovern BH; Cox A; Rice TM; Sacks-Davis R; Bruneau J; Morris MD; Amin J; Schinkel J; Applegate TL; Maher L; Hellard M; Lloyd AR; Prins M; Dore GJ; Grebely J, 2014, 'Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 898A - 899A, presented at 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 07 November 2014 - 11 November 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344483804020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee FJ; Amin J; Carr A, 2013, 'Serious clinical outcomes are under-reported in prospective studies of initial antiretroviral therapy in HIV-1-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Brussels, BELGIUM, pp. A18 - A19, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, Brussels, BELGIUM, 15 October 2013 - 17 October 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hajarizadeh B; Page K; Kim AY; McGovern BH; Cox AL; Rice TM; Sacks-Davis R; Bruneau J; Morris M; Amin J; Grady B; Schinkel J; Maher L; Hellard M; Lloyd AR; Prins M; Grebely J; Dore GJ, 2013, 'EARLY HCVRNA DYNAMICS AND FACTORS ASSOCIATED WITH HIGH EARLY HCVRNA LEVEL DURING ACUTE HCV INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S470 - S471, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, NETHERLANDS, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)61158-7

Grebely J; Page K; Sacks-Davis R; van der Loeff MS; Rice TM; Bruneau J; Morris MD; Hajarizadeh B; Amin J; Cox AL; Kim AY; McGovern BH; George J; Shoukry N; Lauer G; Maher L; Lloyd AR; Hellard M; Dore GJ; Prins M, 2013, 'SPONTANEOUS CLEARANCE OF ACUTE HCV INFECTION IS ASSOCIATED WITH FEMALE SEX, IL28B GENOTYPE AND HCV GENOTYPE 1 INFECTION', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S189 - S189, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, NETHERLANDS, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)60463-8

Aspinall E; Grebely J; Hutchinson S; Innes H; Walter S; Amin J; Yu A; Goldberg D; Krajden M; Law M; Dore G, 2013, 'TRENDS IN MORTALITY AFTER DIAGNOSIS OF HEPATITIS C INFECTION - AN INTERNATIONAL COMPARISON', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, pp. S397 - S398, presented at International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, NETHERLANDS, 24 April 2013 - 28 April 2013, http://dx.doi.org/10.1016/S0168-8278(13)60967-8

Ebeling PR; Haskelberg H; Hoy J; Amin J; Emery S; Carr A, 2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, Gold Coast, AUSTRALIA, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, Gold Coast, AUSTRALIA, 04 September 2011 - 08 September 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309258200234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, London, ENGLAND, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, ENGLAND, 04 November 2010 - 06 November 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200046&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Puls RL; Brown D; Fahey P; Amin J; Breit S; Carr A, 2010, 'Macrophage inhibitory cytokine 1 (MIC-1) serum levels in the Lipodystrophy Case Definition Study', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, London, ENGLAND, pp. A28 - A29, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, London, ENGLAND, 04 November 2010 - 06 November 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500032&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Danta M; Kumarasinghe G; Victor A; Stuart SE; Amin J; Hayward CS; Macdonald PS, 2010, 'LIVER ELASTOGRAPHY IN CARDIAC DISEASE (LECD) STUDY', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 961A - 961A, presented at 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Boston, MA, 29 October 2010 - 02 November 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288775601658&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carey D; Amin J; Emery S, 2009, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir in randomized trials: systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Philadelphia, PA, pp. A58 - A58, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, Philadelphia, PA, 26 October 2009 - 28 October 2009, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen VT; Amin J; Law MG; Dore GJ, 2008, 'Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A343 - A343, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Nguyen VT; Razali K; Amin J; Law MG; Dore GJ, 2006, 'Estimates of Hepatitis B-Realted Liver Cancer Among Vietnam Born Population in Australia', in 18th Annual ASHM Conference, 18th Annual ASHM Conference, Melbourne, pp. 152 - 153, presented at 18th Annual ASHM Conference, Melbourne, 11 October 2006 - 14 October 2006

Amin J; Carr A; Hill A; Emery S; Law M; Cooper DA, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SAN DIEGO, CALIFORNIA, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, SAN DIEGO, CALIFORNIA, 22 September 2002 - 25 September 2002, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Cunningham EB; Dalgard O; Hajarizadeh B; Conway B; Powis J; Bruneau J; Feld J; Read P; Cooper C; Amin J; Bruggmann P; Lacombe K; Stedman C; Hellard M; Marks P; Dunlop A; Moriggia A; Applegate T; Litwin A; Matthews G; Dore G, 2019, 'Reinfection following successful HCV DAA therapy among people with recent injecting drug use', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E732 - E733, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vaccher S; Amin J; Guy R; Jin F; Selvey C; Zablotska-Manos I; Holden J; Price K; Yeung B; Levitt G; Ogilvie E; McNulty A; Smith D; Cooper D; Grulich A, 2018, 'Baseline preferences for daily and non-daily PrEP dosing in EPIC-NSW', in Australasian HIV and AIDS Conference Handbook, Sydney, Australia, presented at Australasian HIV and AIDS Conference, Sydney, Australia, 26 September 2018, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/36f06f6908734ab9a17095cab8705e35

Dalgard O; Grebely J; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop A; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2018, 'Sofosbuvir and Velpatasvir for Hepatitis C Virus Infection in People with Recent Injecting Drug Use (Simplify): An Open-Label, Single-Arm, Phase 4, Multicentre Trial', in HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, PACINI EDITORE, Vol. 20, pp. 14 - 14, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440974900004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer MC; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin AH; Dillon JF; Read P; Gane ED; Dore GJ, 2017, 'EFFICACY AND SAFETY OF SOFOSBUVIR/VELPATASVIR IN PEOPLE WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT INJECTING DRUG USE: THE SIMPLIFY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 34 - 34, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Grebely J; Dalgard O; Conway B; Cunningham E; Bruggmann P; Hajarizadeh B; Amin J; Marks P; Quiene S; Applegate TL; Swan T; Byrne J; Lacalamita M; Dunlop AJ; Bruneau J; Hellard ME; Matthews GV; Powis J; Shaw D; Thurnheer CM; Weltman M; Kronborg I; Cooper C; Feld JJ; Fraser C; Litwin A; Dillon J; Read P; Gane E; Dore GJ, 2017, 'Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S513 - S513, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401056601271&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury FM; Hajarizadeh B; Soker A; Martinez D; Quek C; Cunningham P; Catlett B; Cloherty GA; Marks P; Amin J; Grebely J; Dore GJ; Applegate TL, 2017, 'Hepatitis C virus core antigen and dried blood spots as simplified hepatitis C virus diagnostic tools', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S710 - S710, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31901-3

Larney S; Grebely J; Degenhardt L; Amin J; Law M; Alavi M; Dore GJ, 2016, 'EXPOSURE TO OPIOID SUBSTITUTION THERAPY FOLLOWING HEPATITIS C NOTIFICATION: IMPLICATIONS FOR PROVISION OF ANTIVIRAL THERAPIES IN DRUG TREATMENT SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 48 - 48, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zablotska I; Grulich AE; Guy R; Amin J; Selvey C; Schmidt H-M; Price K; Cooper D, 2016, 'Expanded PrEP implementation in communities in NSW, Australia (EPIC-NSW): evidence-based implementation study', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 19, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300219&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Alavi M; Janjua N; Yu A; Grebely J; Aspinall E; Innes H; Valerio H; Hayes P; Krajden M; Amin J; Law M; George J; Goldberg D; Hutchinson S; Dore G, 2016, 'DOES ALCOHOL DEPENDENCY EXPLAIN DIFFERENCES IN RATES OF DECOMPENSATED CIRRHOSIS AMONG PEOPLE WITH A HEPATITIS C NOTIFICATION? AN INTERNATIONAL COMPARISON', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Barcelona, SPAIN, Vol. 64, pp. S462 - S463, presented at EASL International Liver Congress, Barcelona, SPAIN, 13 April 2016 - 17 April 2016, http://dx.doi.org/10.1016/S0168-8278(16)00776-5

Muscatello DJ; Amin J; MacIntyre CR; Newall AT; Rawlinson WD; Sintchenko V; Gilmour R; Thackway S, 2014, 'Under-ascertainment of Illness due to Influenza in Administrative Databases, a Population-based Record Linkage Study', in Online J Public Health Inform, University of Illinois at Chicago Library, Vol. 6, pp. e169, http://dx.doi.org/10.5210/ojphi.v6i1.5189

van Leeuwen M; Grulich A; Webster A; McDonald S; McCredie M; Stewart J; Amin J; Kaldor J; Chapman J; Vajdic C, 2008, 'CURRENCY OF RECEIPT OF IMMUNOSUPPRESSIVE AGENTS AND OTHER RISK FACTORS FOR LIP CANCER FOLLOWING RENAL TRANSPLANTATION', in Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 86, pp. 101 - 101, http://dx.doi.org/10.1097/01.tp.0000332547.88129.b9

Vajdic C; van Leeuwen M; Amin J; McDonald S; McCredie M; Stewart J; Webster A; Kaldor J; Chapman J; Grulich A, 2008, 'RISK OF CUTANEOUS MELANOMA DOES NOT INCREASE OVER TIME AFTER RENAL TRANSPLANTATION', in Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 86, pp. 296 - 296, http://dx.doi.org/10.1097/01.tp.0000331939.20064.c4

van Leeuwen M; Vajdic C; Webster A; McDonald S; McCredie M; Stewart J; Amin J; Kaldor J; Chapman J; Grulich A, 2008, 'RISK FOR NON-HODGKIN LYMPHOMA FOLLOWING RENAL TRANSPLANTATION IS ASSOCIATED WITH CURRENCY OF RECEIPT OF IMMUNOSUPPRESSION AND REVERTS TO NORMAL ON CESSATION', in Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 86, pp. 294 - 294, http://dx.doi.org/10.1097/01.tp.0000331934.97193.4e

Grulich A; McCredie M; van Leeuwen M; Amin J; Stewart J; McDonald S; Webster A; Kaldor J; Chapman J; Vajdic C, 2008, 'RATES OF HUMAN PAPILLOMAVIRUS (HPV)-RELATED CANCERS ARE INCREASED IN RENAL TRANSPLANT RECIPIENTS AND RETURN TO LOW LEVELS ON CESSATION OF IMMUNE SUPPRESSION.', in Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 86, pp. 295 - 295, http://dx.doi.org/10.1097/01.tp.0000331938.42935.c5

Micallef JM; Jauncey M; Amin J; Rawlinson W; Gilmour S; van Beek I; Kaldor JM; White PA; Dore GJ, 2003, 'Hepatitis C virus reinfection within a cohort of injecting drug users.', in HEPATOLOGY, W B SAUNDERS CO, BOSTON, MASSACHUSETTS, Vol. 38, pp. 266A - 266A, presented at 54th Annual Meeting of the American-Association-for-the-Study-of-Liver-Disease, BOSTON, MASSACHUSETTS, 24 October 2003 - 28 October 2003, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000185816700230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1